1
|
Chaaban S, Istvan M, Schreck B, Laigo P, Rousselet M, Grall-Bronnec M, Pain S, Victorri-Vigneau C. Cannabis use and dependence among festival attendees: results from the French OCTOPUS survey. BMC Public Health 2024; 24:992. [PMID: 38594675 PMCID: PMC11003156 DOI: 10.1186/s12889-024-18496-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2023] [Accepted: 04/01/2024] [Indexed: 04/11/2024] Open
Abstract
BACKGROUND Chronic use of cannabis is associated with an increased risk of psychosocial, mental and physical health impairments. Sociohealth institutions reach a very limited proportion of cannabis users in need of treatment. Using data collected from festival attendees, this study aimed to estimate the prevalence of dependent cannabis users and to characterize cannabis dependence. METHODS We used data from the cross-sectional OCTOPUS survey carried out at 13 music events in the French department of Loire-Atlantique between July 2017 and July 2018. 383 participants aged 18 or older underwent a face-to-face interview about their basic sociodemographics, tobacco use, alcohol use and past-year substance use. Using the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV) criteria, we estimated the prevalence of dependent cannabis users and characterized their dependence. RESULTS More than two-thirds of participants reported that they had used cannabis in the past 12 months. Among 194 regular cannabis users (at least monthly), 63.4% were dependent. At least 40% of regular users reported health and/or social consequences of cannabis use. Compared to nondependent cannabis users, dependent cannabis users were more likely to be stimulant users and hallucinogen users. CONCLUSIONS Dependent cannabis use is common among festival attendees, especially among stimulant or hallucinogen users. Festival settings may be important arenas for i) implementing efficient harm reduction measures to prevent dependence and ii) providing information on care structures and promoting the use of care to dependent users. In addition, healthcare professionals should be aware of trends in polysubstance use among dependent cannabis users.
Collapse
Affiliation(s)
- Sarah Chaaban
- Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, Nantes Université, CHU Nantes, F-44000, Nantes, France
| | - Marion Istvan
- Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, Nantes Université, CHU Nantes, F-44000, Nantes, France
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000, Nantes, France
| | - Benoit Schreck
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000, Nantes, France
- UIC Psychiatrie et Santé Mentale, Nantes Université, CHU Nantes, F-44000, Nantes, France
| | - Pauline Laigo
- Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, Nantes Université, CHU Nantes, F-44000, Nantes, France
| | - Morgane Rousselet
- Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, Nantes Université, CHU Nantes, F-44000, Nantes, France.
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000, Nantes, France.
- UIC Psychiatrie et Santé Mentale, Nantes Université, CHU Nantes, F-44000, Nantes, France.
| | - Marie Grall-Bronnec
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000, Nantes, France
- UIC Psychiatrie et Santé Mentale, Nantes Université, CHU Nantes, F-44000, Nantes, France
| | - Stéphanie Pain
- Centre d'addictovigilance, Service de Pharmacologie Clinique, CHU de Poitiers, 86000, Poitiers, France
- Laboratoire de Neurosciences Expérimentales et Cliniques, INSERM U-1084, Université de Poitiers, 86000, Poitiers, France
| | - Caroline Victorri-Vigneau
- Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, Nantes Université, CHU Nantes, F-44000, Nantes, France
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000, Nantes, France
| |
Collapse
|
2
|
Grall-Bronnec M, Verholleman A, Victorri-Vigneau C, Leboucher J, Thiabaud E, Hardouin JB, Schreck B, Rouaud T, Roy M, Derkinderen P, Challet-Bouju G. Parkinson's Disease, Impulsive-Compulsive Behaviors, and Health-Related Quality of Life. J Mov Disord 2024; 17:82-88. [PMID: 37926510 PMCID: PMC10846971 DOI: 10.14802/jmd.23042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/01/2023] [Revised: 06/30/2023] [Accepted: 11/03/2023] [Indexed: 11/07/2023] Open
Abstract
OBJECTIVE A large body of literature has examined the links between the use of dopamine replacement therapy (DRT) in Parkinson's disease (PD) and the development of "impulsive-compulsive behaviors (ICBs)." Little is known regarding the link between the development of ICBs and health-related quality of life (HRQOL). We aimed to explore the factors that are associated with poorer HRQOL, especially in relation to DRT-induced ICBs, in a sample of PD patients. METHODS This PARKADD (PARK: PARKinson's disease; ADD: behavioral ADDictions) study was a prospective case‒control study initially designed to assess the factors associated with ICBs in PD patients. A prospective clinical follow-up was added, aiming to capture the long-term evolution of HRQOL in relation to ICBs occurring or worsening after the beginning of PD. We focused on sociodemographic and PD characteristics and the history or presence of ICBs. HRQOL was measured using the Parkinson's Disease Questionnaire-8. A multivariate linear regression was performed to identify factors related to poorer HRQOL. RESULTS A total of 169 patients were eligible for the follow-up study. The presence of an ICB, a higher levodopa equivalent daily dose (LEDD) and a longer PD duration were significantly associated with poorer HRQOL, with an interaction between LEDD and PD duration. CONCLUSION The presence of an ICB was related to poorer HRQOL and should be considered a crucial factor for the management of PD patients. Several studies were recently published that provide guidelines for the management of these patients, with recommendations based on two key principles: prevention and specific treatment.
Collapse
Affiliation(s)
- Marie Grall-Bronnec
- Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients Centered Outcomes And HEalth ResEarch, SPHERE, Nantes, France
| | - Audrey Verholleman
- Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France
| | - Caroline Victorri-Vigneau
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients Centered Outcomes And HEalth ResEarch, SPHERE, Nantes, France
- Nantes Université, CHU Nantes, Department of Pharmacology, Nantes, France
| | - Juliette Leboucher
- Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France
| | - Elsa Thiabaud
- Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France
| | - Jean-Benoit Hardouin
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients Centered Outcomes And HEalth ResEarch, SPHERE, Nantes, France
- Nantes Université, CHU Nantes, Biostatistics and Methodology Unit, Department of Clinical Research and Innovation, Nantes, France
| | - Benoit Schreck
- Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients Centered Outcomes And HEalth ResEarch, SPHERE, Nantes, France
| | - Tiphaine Rouaud
- Nantes Université, CHU Nantes, Department of Neurology, Nantes, France
| | - Monica Roy
- Nantes Université, CHU Nantes, Department of Neurology, Nantes, France
| | - Pascal Derkinderen
- Nantes Université, CHU Nantes, Department of Neurology, Nantes, France
- Nantes Université, CHU Nantes, INSERM, Nantes, France
| | - Gaëlle Challet-Bouju
- Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients Centered Outcomes And HEalth ResEarch, SPHERE, Nantes, France
| |
Collapse
|
3
|
Istvan M, Bresdin V, Mainguy M, Laigo P, Grall-Bronnec M, Eudeline V, Guillet JE, Guillo M, Babonnaud L, Jolliet P, Schreck B, Victorri-Vigneau C. First results of the French OCTOPUS survey among festival attendees: a latent class analysis. Harm Reduct J 2023; 20:43. [PMID: 36991395 PMCID: PMC10057684 DOI: 10.1186/s12954-023-00770-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2022] [Accepted: 03/15/2023] [Indexed: 03/31/2023] Open
Abstract
BACKGROUND Illicit substance use has constantly evolved over the years, particularly in the party scene. Monitoring these changes is essential to adapt harm reduction strategies. The OCTOPUS survey was implemented to enhance knowledge on drug use at music festivals. The objective of the work presented here was to describe drug use and to characterize profiles of substance use in music festival attendees. METHODS OCTOPUS was a cross-sectional survey carried out during 13 various music festivals (dub, eclectic and electronic music) in the Loire-Atlantique department (France) from July 2017 to July 2018. Participants were festival attendees. Data were collected by trained research staff using a face-to-face structured interview. We analysed the use of illicit drugs in the last 12 months to describe the prevalence of use and to characterize the profile of substance use using a latent class analysis. RESULTS In total, 383 festival attendees were included. Of 314 (82%) participants who reported drug use, the most reported drugs were cannabis, ecstasy/MDMA and cocaine. We identified two profiles of drug use: (i) a "no/low polysubstance use" profile mainly characterized by the use of "classic" stimulants (ecstasy/MDMA, cocaine) and (ii) "moderate/extensive polysubstance use", with high probabilities of "classic" stimulants use and especially other drugs reported: speed, ketamine, new psychoactive substances (NPSs). CONCLUSION We observed frequent polysubstance use in festival attendees. Harm reduction should be targeted at the increased risk of toxicity linked to polysubstance use, and the reduction in harm caused by particular drugs (ketamine, NPS, speed) could be further strengthened.
Collapse
Affiliation(s)
- Marion Istvan
- Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000, Nantes, France.
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000, Nantes, France.
| | - Vincent Bresdin
- Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000, Nantes, France
| | - Marie Mainguy
- Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000, Nantes, France
| | - Pauline Laigo
- Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000, Nantes, France
| | - Marie Grall-Bronnec
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000, Nantes, France
- Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, F-44000, Nantes, France
| | - Vincent Eudeline
- OPPELIA, Association de Prévention et de Soin en Addictologie, Nantes et St Nazaire, France
| | - Jean-Emmanuel Guillet
- OPPELIA, Association de Prévention et de Soin en Addictologie, Nantes et St Nazaire, France
| | - Manon Guillo
- Techno + Nantes, Association de Santé Communautaire en Milieu Techno, Nantes, France
| | - Laurent Babonnaud
- AIDES Nantes, association de soutien et accompagnement des personnes, Actions de prévention et de réduction des risques du VIH/SIDA et des hépatites, Nantes, France
| | - Pascale Jolliet
- Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000, Nantes, France
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000, Nantes, France
| | - Benoit Schreck
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000, Nantes, France
- Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, F-44000, Nantes, France
| | - Caroline Victorri-Vigneau
- Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000, Nantes, France
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients-centered outcomes and HEalth Research, SPHERE, F-44000, Nantes, France
| |
Collapse
|
4
|
Schreck B, Istvan M, Guerlais M, Laforgue EJ, Gérardin M, Grall-Bronnec M, Aquizerate A, Victorri-Vigneau C. New Psychoactive Substances, New Behaviours, New Drug-drug Interactions: Pharmacology of a Slam Session. Curr Drug Metab 2023; 24:80-91. [PMID: 36852802 DOI: 10.2174/1389200224666230228103922] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2022] [Revised: 01/04/2023] [Accepted: 01/26/2023] [Indexed: 03/01/2023]
Abstract
BACKGROUND Slamming has been increasing internationally for ten years, mostly among men who have sex with men. Slamming consists of injecting psychostimulants (including new psychoactive substances-NPS) intravenously to increase sexual performance. OBJECTIVE The objective of our work was to analyse drug-drug interactions related to slamming. METHODS Drawing upon a reported case of a slam session describing hour by hour the intake of substances, we performed a drug-interaction analysis using international references and a comprehensive literature review. High doses of sildenafil, GBL and 3-MMC were reported during the 40-hour session described. The specific drug-interaction research was performed using 9 references and 65 of the 209 records identified in the literature review. RESULTS Pharmacological data regarding nonmedicated substances were scarce. Regarding pharmacodynamics, the risk was high at the cardiovascular level and was related to the vasodilatation effect of sildenafil and the adrenergic and serotoninergic properties of stimulants; this risk may increase with usual treatment (involving other vasodilators or central depressants). Regarding pharmacokinetics, the major interactions concerned metabolism by CYP3A4 and CYP2C9, leading to interactions, particularly with HIV medication. CONCLUSION This innovative work provides pharmacological information on drugs that are commonly used in slamming, allowing the development of effective medical-management protocols and the provision of risk-reduction counselling.
Collapse
Affiliation(s)
- Benoit Schreck
- Nantes Université, CHU Nantes, UIC Psychiatrie et Santé Mentale, F-44000 Nantes, France.,Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients centered outcomes and HEalth ResEarch, SPHERE, F-44000 Nantes, France
| | - Marion Istvan
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients centered outcomes and HEalth ResEarch, SPHERE, F-44000 Nantes, France.,Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000 Nantes, France
| | - Marylène Guerlais
- Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000 Nantes, France
| | - Edouard-Jules Laforgue
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients centered outcomes and HEalth ResEarch, SPHERE, F-44000 Nantes, France.,Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000 Nantes, France
| | - Marie Gérardin
- Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000 Nantes, France
| | - Marie Grall-Bronnec
- Nantes Université CHU Nantes, UIC Psychiatrie et Santé Mentale, F-44000 Nantes, France Nantes France.,Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients centered outcomes and HEalth ResEarch, SPHERE, F-44000 Nantes, France
| | - Aurélie Aquizerate
- Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000 Nantes, France
| | - Caroline Victorri-Vigneau
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients centered outcomes and HEalth ResEarch, SPHERE, F-44000 Nantes, France.,Nantes Université, CHU Nantes, Centre d'Evaluation et d'Information sur la Pharmacodépendance-Addictovigilance (CEIP-A), Service de Pharmacologie Clinique, F-44000 Nantes, France
| |
Collapse
|
5
|
Grall-Bronnec M, Victorri-Vigneau C, Rouaud T, Verholleman A, Schreck B, Leboucher J, Thiabaud E, Feuillet F, Roy M, Hardouin JB, Guillou-Landreat M, Derkinderen P, Challet-Bouju G. Parkinson's disease and iatrogenic impulsive-compulsive behaviors: A case/non-case study to build a complete model of individual vulnerability. J Behav Addict 2022; 11:766-777. [PMID: 35960604 PMCID: PMC9872544 DOI: 10.1556/2006.2022.00051] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/03/2021] [Revised: 01/19/2022] [Accepted: 07/12/2022] [Indexed: 02/03/2023] Open
Abstract
BACKGROUND AND AIMS Parkinson's disease (PD) is one of the most prevalent neurodegenerative diseases. First-line medications consist of drugs that act by counteracting dopamine deficiency in the basal ganglia. Unfortunately, iatrogenic impulsive-compulsive behaviors (ICBs) can occur in up to 20% of PD patients over the course of their illness. ICBs must be considered multifactorial disorders that reflect the interactions of the medication with an individual's vulnerability and the underlying neurobiology of PD. We aimed to explore the predictive genetic, psychopathological and neurological factors involved in the development of ICBs in PD patients by building a complete model of individual vulnerability. METHODS The PARKADD study was a case/non-case study. A total of 225 patients were enrolled ("ICB" group, N = 75; "no ICB" group, N = 150), and 163 agreed to provide saliva samples for genetic analysis. Sociodemographic, neurological and psychiatric characteristics were assessed, and genotyping for the characterization of polymorphisms related to dopaminergic and opioid systems was performed. RESULTS Factors associated with "ICBs" were younger age of PD onset, personal history of ICB prior to PD onset and higher scores on the urgency and sensation seeking facets of impulsivity. No gene variant was significantly associated, but the association with the opioid receptor mu 1 (OPRM1) rs1799971 polymorphism was close to significance. DISCUSSION AND CONCLUSIONS The influence of gene-environment interactions probably exists, and additional studies are needed to decipher the possible role of the opioid system in the development of ICBs in PD patients.
Collapse
Affiliation(s)
- Marie Grall-Bronnec
- CHU Nantes, Addictology and Psychiatry Department, Nantes, France,Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients centered outcomes and HEalth ResEarch, SPHERE, F-44000 Nantes, France,Corresponding author. Tel.: +33 (0)2 40 84 61 16; fax: 33 (0)2 40 84 61 18. E-mail:
| | - Caroline Victorri-Vigneau
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients centered outcomes and HEalth ResEarch, SPHERE, F-44000 Nantes, France,CHU Nantes, Pharmacology Department, Nantes, France
| | | | | | - Benoit Schreck
- CHU Nantes, Addictology and Psychiatry Department, Nantes, France,Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients centered outcomes and HEalth ResEarch, SPHERE, F-44000 Nantes, France
| | | | - Elsa Thiabaud
- CHU Nantes, Addictology and Psychiatry Department, Nantes, France
| | - Fanny Feuillet
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients centered outcomes and HEalth ResEarch, SPHERE, F-44000 Nantes, France,CHU Nantes, DRCI, Methodology and Biostatistic Department, Nantes, France
| | - Monica Roy
- CHU Nantes, Neurology Department, Nantes, France
| | - Jean-Benoit Hardouin
- Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients centered outcomes and HEalth ResEarch, SPHERE, F-44000 Nantes, France,CHU Nantes, DRCI, Methodology and Biostatistic Department, Nantes, France
| | - Morgane Guillou-Landreat
- CHU Brest, Addictology Department, Nantes, France,Université de Bretagne Occidentale, ERCR SPURBO, Brest, France
| | - Pascal Derkinderen
- CHU Nantes, Neurology Department, Nantes, France,Université de Nantes, Inserm U913, Nantes, France
| | - Gaëlle Challet-Bouju
- CHU Nantes, Addictology and Psychiatry Department, Nantes, France,Nantes Université, Univ Tours, CHU Nantes, CHU Tours, INSERM, MethodS in Patients centered outcomes and HEalth ResEarch, SPHERE, F-44000 Nantes, France
| |
Collapse
|
6
|
Chirio-Espitalier M, Schreck B, Duval M, Hardouin JB, Moret L, Bronnec MG. Exploring the Personal Recovery Construct in Bipolar Disorders: Definition, Usage and Measurement. A Systematic Review. Front Psychiatry 2022; 13:876761. [PMID: 35815013 PMCID: PMC9263970 DOI: 10.3389/fpsyt.2022.876761] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/15/2022] [Accepted: 05/30/2022] [Indexed: 11/25/2022] Open
Abstract
Personal recovery from psychiatric disorders is a journey toward a satisfying and hopeful life despite the possible persistence of symptoms. This concept has gained interest and become an increasingly important goal in mental health care programmes. Personal Recovery is well described in the context of severe mental illnesses in general, but little is known about this journey in bipolar disorders and the factors underlying it. A systematic review was conducted according to the PRISMA recommendations, focusing on studies exploring personal recovery in bipolar disorder specifically. The latter have integrated a comprehensive approach to the concept, the existing means of measurement or have explored the levers of recovery in care. Twenty-four articles were selected, including seven qualitative, 12 observational, and five interventional studies. The Bipolar Recovery Questionnaire was the only scale developed de novo from qualitative work with bipolar people. Personal recovery did not correlate very closely with symptomatology. Some elements of personal recovery in bipolar disorder were similar to those in other severe mental illnesses: meaning in life, self-determination, hope, and low self-stigma. Specific levers differed: mental relationships with mood swings, including acceptance and decrease in hypervigilance, and openness to others, including trust and closeness. The studies highlighted the role of caregiver posture and the quality of communication within care, as well as the knowledge gained from peers. The choice to exclude articles not focused on bipolar disorder resulted in the provision of very specific information, and the small number of articles to date may limit the scope of the evidence. New components of personal recovery in bipolar disorder emerged from this review; these components could be taken into account in the construction of care tools, as well as in the caregiving posture. Strengthening skills of openness to others could also be a central target of recovery-focused care.
Collapse
Affiliation(s)
- Marion Chirio-Espitalier
- Nantes University, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France.,Nantes University, Univ Tours, CHU Nantes, INSERM, MethodS in Patients Centered Outcomes and HEalth ResEarch, SPHERE, Nantes, France
| | - Benoit Schreck
- Nantes University, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France.,Nantes University, Univ Tours, CHU Nantes, INSERM, MethodS in Patients Centered Outcomes and HEalth ResEarch, SPHERE, Nantes, France
| | - Melanie Duval
- Department of Public Health, University Hospital of Nantes, Nantes, France
| | - Jean-Benoit Hardouin
- Nantes University, Univ Tours, CHU Nantes, INSERM, MethodS in Patients Centered Outcomes and HEalth ResEarch, SPHERE, Nantes, France
| | - Leila Moret
- Nantes University, Univ Tours, CHU Nantes, INSERM, MethodS in Patients Centered Outcomes and HEalth ResEarch, SPHERE, Nantes, France.,Department of Public Health, University Hospital of Nantes, Nantes, France
| | - Marie Grall Bronnec
- Nantes University, CHU Nantes, UIC Psychiatrie et Santé Mentale, Nantes, France.,Nantes University, Univ Tours, CHU Nantes, INSERM, MethodS in Patients Centered Outcomes and HEalth ResEarch, SPHERE, Nantes, France
| |
Collapse
|
7
|
Jobert A, Istvan M, Laforgue EJ, Schreck B, Victorri-Vigneau C. Regulatory Framework Implementation for the Prescription of Zolpidem in France, What Impact in the Older People? Int J Environ Res Public Health 2021; 18:ijerph182212099. [PMID: 34831853 PMCID: PMC8619144 DOI: 10.3390/ijerph182212099] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/13/2021] [Revised: 11/09/2021] [Accepted: 11/10/2021] [Indexed: 12/04/2022]
Abstract
Background: Zolpidem is one of the most prescribed hypnotic drugs. In 2001, the World Health Organization alerted a risk of pharmacodependence associated with zolpidem. The French health authority decided in 2017 to enforce security on the prescription of zolpidem to reduce those risks. The aim of our study was to evaluate the impact of regulatory framework implementation, secure prescription pad, on the prevalence and incidence of prescriptions of zolpidem according to the age. Methods: This study was based on an observational study using the French healthcare data system. Two age categories were defined: “younger” and “older” (<65 years, ≥65 years); in order to study the evolution of prevalence and incidence of zolpidem use in our two groups, two periods were defined, before and after the implementation of the measure. Results: The prevalence decreased in the younger population by 51% (4012 vs. 7948 consumers), while that of the older population decreased by 42% (4151 vs. 7282). This difference in our two groups, with a greater decrease in the younger people, is statistically significant compared to the older people. Conclusion: Our study showed that regulatory framework implementation and mandatory secure prescription pad is more effective for decreasing prevalence of zolpidem prescription for younger people compared to older people.
Collapse
Affiliation(s)
- Alexandra Jobert
- Nantes Université, Univ. Tours, INSERM, MethodS in Patients-Centered Outcomes and HEalth Research, SPHERE, F-44000 Nantes, France; (M.I.); (E.-J.L.); (B.S.); (C.V.-V.)
- CHU Nantes, Research and Innovation Department, 5 allée de l’île gloriette, CEDEX, 44093 Nantes, France
- Correspondence:
| | - Marion Istvan
- Nantes Université, Univ. Tours, INSERM, MethodS in Patients-Centered Outcomes and HEalth Research, SPHERE, F-44000 Nantes, France; (M.I.); (E.-J.L.); (B.S.); (C.V.-V.)
- CHU Nantes, Centre for Evaluation and Information on Pharmacodependence, Clinical Pharmacology Department, CEDEX, 44093 Nantes, France
| | - Edouard-Jules Laforgue
- Nantes Université, Univ. Tours, INSERM, MethodS in Patients-Centered Outcomes and HEalth Research, SPHERE, F-44000 Nantes, France; (M.I.); (E.-J.L.); (B.S.); (C.V.-V.)
- CHU Nantes, Centre for Evaluation and Information on Pharmacodependence, Clinical Pharmacology Department, CEDEX, 44093 Nantes, France
- CHU Nantes, Addictology and Liaison-Psychiatry Department, CEDEX, 44093 Nantes, France
| | - Benoit Schreck
- Nantes Université, Univ. Tours, INSERM, MethodS in Patients-Centered Outcomes and HEalth Research, SPHERE, F-44000 Nantes, France; (M.I.); (E.-J.L.); (B.S.); (C.V.-V.)
- CHU Nantes, Addictology and Liaison-Psychiatry Department, CEDEX, 44093 Nantes, France
| | - Caroline Victorri-Vigneau
- Nantes Université, Univ. Tours, INSERM, MethodS in Patients-Centered Outcomes and HEalth Research, SPHERE, F-44000 Nantes, France; (M.I.); (E.-J.L.); (B.S.); (C.V.-V.)
- CHU Nantes, Centre for Evaluation and Information on Pharmacodependence, Clinical Pharmacology Department, CEDEX, 44093 Nantes, France
| |
Collapse
|
8
|
Schreck B, Victorri-Vigneau C, Guerlais M, Laforgue E, Grall-Bronnec M. Slam Practice: A Review of the Literature. Eur Addict Res 2021; 27:161-178. [PMID: 33279895 DOI: 10.1159/000511897] [Citation(s) in RCA: 10] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/20/2019] [Accepted: 09/25/2020] [Indexed: 11/19/2022]
Abstract
BACKGROUND Slamming has been developing since 2011 as a new international phenomenon, mostly among men who have sex with men (MSM). It consists of intravenous drug injection before or during planned sexual activity to sustain, enhance, disinhibit, or facilitate the experience. We aimed to synthesize the available published evidence through a systematic literature review in order to precisely describe this phenomenon and to better characterize the population engaging in this practice and its specific motives. METHODS A systematic review of the available literature was conducted to identify all relevant publications using PubMed, Psyc-INFO, the Cochrane Library, and ScienceDirect. To complete the review, we followed the recommendations of the "Preferred Reporting Items for Systematic Reviews and Meta-Analyses" method. We limited the search to studies published between January 2008 and May 2020. RESULTS Our search identified 530 publications, of which 27 were included in the final data synthesis. One study focused on heterosexual and homosexual subpopulations, and all other studies focused on MSM-specific samples. Among MSM, slam prevalence was extremely variable, ranging from 2 to 91%; regarding other sexually active subjects, prevalence ranged from 7 to 14%. The prevalence of HIV-positive subjects varied widely across studies, ranging from 0.6 to 100%. We found less data about hepatitis C virus serostatus, ranging from 3 to 100%. Methamphetamine and mephedrone were the 2 most used drugs. DISCUSSION/CONCLUSION The data we found in international literature were very heterogeneous and from poorly reproducible studies. The definition of slamming in the international literature is not always clear, which limits the completeness of the collected data. This topic has been open to studies only recently; however, health professionals must be trained in the management of this practice, considering its risks in the short and medium terms and its addictive potential. We provided and discussed recommendations and potential future directions.
Collapse
Affiliation(s)
- Benoit Schreck
- Department of Addictology and Psychiatry, CHU Nantes, Nantes, France, .,Universités de Nantes et de Tours, French Institute of Health and Medical Research, INSERM UMR 1246 SPHERE, Nantes, France,
| | - Caroline Victorri-Vigneau
- Universités de Nantes et de Tours, French Institute of Health and Medical Research, INSERM UMR 1246 SPHERE, Nantes, France.,Department of Clinical Pharmacology, CHU Nantes, Nantes, France
| | | | - Edouard Laforgue
- Department of Addictology and Psychiatry, CHU Nantes, Nantes, France.,Universités de Nantes et de Tours, French Institute of Health and Medical Research, INSERM UMR 1246 SPHERE, Nantes, France
| | - Marie Grall-Bronnec
- Department of Addictology and Psychiatry, CHU Nantes, Nantes, France.,Universités de Nantes et de Tours, French Institute of Health and Medical Research, INSERM UMR 1246 SPHERE, Nantes, France
| |
Collapse
|
9
|
LaForgue EJ, Lesage A, Schreck B, Guerlais M, Victorri-Vigneau C. Cannabinoid Hyperemesis Syndrome Among Pregnant Women: Beyond Diagnosis—Potentially Harmful Consequences. J Stud Alcohol Drugs 2020. [DOI: 10.15288/jsad.2020.81.824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022] Open
Affiliation(s)
- Edouard-Jules LaForgue
- Centre Hospitalier Universitaire de Nantes, University Hospital, Clinical Pharmacology Department, France
- Centre Hospitalier Universitaire de Nantes, University Hospital, Addictology and Liaison-Psychiatry Department, France
- INSERM UMR 1246, SPHERE, Methods in Patients-Centered Outcomes and Health Research, Nantes and Tours University, France
| | - Aurore Lesage
- Centre Hospitalier Universitaire de Nantes, University Hospital, Clinical Pharmacology Department, France
| | - Benoit Schreck
- Centre Hospitalier Universitaire de Nantes, University Hospital, Addictology and Liaison-Psychiatry Department, France
- INSERM UMR 1246, SPHERE, Methods in Patients-Centered Outcomes and Health Research, Nantes and Tours University, France
| | - Marylène Guerlais
- Centre Hospitalier Universitaire de Nantes, University Hospital, Clinical Pharmacology Department, France
| | - Caroline Victorri-Vigneau
- Centre Hospitalier Universitaire de Nantes, University Hospital, Clinical Pharmacology Department, France
- INSERM UMR 1246, SPHERE, Methods in Patients-Centered Outcomes and Health Research, Nantes and Tours University, France
| |
Collapse
|
10
|
LaForgue EJ, Lesage A, Schreck B, Guerlais M, Victorri-Vigneau C. Cannabinoid Hyperemesis Syndrome Among Pregnant Women: Beyond Diagnosis--Potentially Harmful Consequences. J Stud Alcohol Drugs 2020; 81:824-825. [PMID: 33308413] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/12/2023] Open
Affiliation(s)
- Edouard-Jules LaForgue
- Centre Hospitalier Universitaire de Nantes, University Hospital, Clinical Pharmacology Department, France
- Centre Hospitalier Universitaire de Nantes, University Hospital, Addictology and Liaison-Psychiatry Department, France
- INSERM UMR 1246, SPHERE, Methods in Patients-Centered Outcomes and Health Research, Nantes and Tours University, France
| | - Aurore Lesage
- Centre Hospitalier Universitaire de Nantes, University Hospital, Clinical Pharmacology Department, France
| | - Benoit Schreck
- Centre Hospitalier Universitaire de Nantes, University Hospital, Addictology and Liaison-Psychiatry Department, France
- INSERM UMR 1246, SPHERE, Methods in Patients-Centered Outcomes and Health Research, Nantes and Tours University, France
| | - Marylène Guerlais
- Centre Hospitalier Universitaire de Nantes, University Hospital, Clinical Pharmacology Department, France
| | - Caroline Victorri-Vigneau
- Centre Hospitalier Universitaire de Nantes, University Hospital, Clinical Pharmacology Department, France
- INSERM UMR 1246, SPHERE, Methods in Patients-Centered Outcomes and Health Research, Nantes and Tours University, France
| |
Collapse
|
11
|
Schreck B, Guerlais M, Laforgue E, Bichon C, Grall-Bronnec M, Victorri-Vigneau C. Cathinone Use Disorder in the Context of Slam Practice: New Pharmacological and Clinical Challenges. Front Psychiatry 2020; 11:705. [PMID: 32792999 PMCID: PMC7387686 DOI: 10.3389/fpsyt.2020.00705] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/04/2020] [Accepted: 07/06/2020] [Indexed: 12/15/2022] Open
Abstract
BACKGROUND "Slam" has emerged since 2008 as a new international phenomenon among men who have sex with men (MSM); it consists of the intravenous injection of drugs before or during planned sexual activity. The practice of slam is associated with the use of psychostimulants, including synthetic cathinones. METHODS All spontaneous notifications (Nots) of slam practice reported between January 2012 and October 2019 at the Nantes addictovigilance center in France were collected and analyzed. The purpose of this work was to analyze cases of slam to characterize cathinone use disorder according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) and to further our knowledge of slam practice based on data on drug use, risk taking and harmful consequences. RESULTS We collected 39 slam Nots. The severity of cathinone use disorder was mild, moderate and severe for 18%, 12%, and 58% of the patients, respectively. "Much time spent using cathinone" was the diagnostic criterion most often cited (82%). CONCLUSIONS To the best of our knowledge, our study is the first to evaluate the presence of a cathinone use disorder. Cathinone use disorder seems particularly important in this population of users, and negative consequences of slam practice appear quickly.
Collapse
Affiliation(s)
- Benoit Schreck
- Department of Addictology and Psychiatry, CHU Nantes, Nantes, France.,French Institute of Health and Medical Research, Universités de Nantes et de Tours, INSERM UMR 1246 SPHERE, Nantes, France.,Department of Clinical Pharmacology, CHU Nantes, Nantes, France
| | | | - Edouard Laforgue
- Department of Addictology and Psychiatry, CHU Nantes, Nantes, France.,French Institute of Health and Medical Research, Universités de Nantes et de Tours, INSERM UMR 1246 SPHERE, Nantes, France.,Department of Clinical Pharmacology, CHU Nantes, Nantes, France
| | - Célia Bichon
- Department of Clinical Pharmacology, CHU Nantes, Nantes, France
| | - Marie Grall-Bronnec
- Department of Addictology and Psychiatry, CHU Nantes, Nantes, France.,French Institute of Health and Medical Research, Universités de Nantes et de Tours, INSERM UMR 1246 SPHERE, Nantes, France.,Department of Clinical Pharmacology, CHU Nantes, Nantes, France
| | - Caroline Victorri-Vigneau
- French Institute of Health and Medical Research, Universités de Nantes et de Tours, INSERM UMR 1246 SPHERE, Nantes, France.,Department of Clinical Pharmacology, CHU Nantes, Nantes, France
| |
Collapse
|
12
|
Cattarin S, Mengoli G, Musiani M, Schreck B, Zecchin S. Électrodes modifiées par oxydation du carbazole et des carbazoles N-substitués en milieu acide. ACTA ACUST UNITED AC 2017. [DOI: 10.1051/jcp/1989860163] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
13
|
Kaiser M, Burg B, Köster R, Schreck B. Anwendung von Tensiden bei der mechanischen Flüssigkeitsabtrennung mechanischen Flüssigkeitsabtrennung. CHEM-ING-TECH 1992. [DOI: 10.1002/cite.330640988] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
14
|
Lehmann KM, Brauns-Packenius B, Schreck B. [Error-free model preparation. Air inclusion is avoidable]. Dent Labor (Munch) 1986; 34:1229-31. [PMID: 3527796] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
|
15
|
Heilmann E, Schreck B. [Morbidity of chronic lymphatic leukemia]. Med Welt 1977; 28:2022-5. [PMID: 600078] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|